Cocrystal Pharma ratifies exec salary hikes to $416K, $200K bonuses, and RSU grants

Cocrystal Pharma, Inc.

James Martin (CFO/co-CEO) and Dr. Sam Lee (President/co-CEO) base salary increased from $400K to $416K, plus $200K bonus and 40,000 RSUs each.
Non-employee director grants: Dr. Kornberg $60.5K cash + $100K SAB stipend + 28,109 RSUs; Dr. Frost $44,770 + 27,100 RSUs; Steven Rubin $82,280 + 18,957 RSUs.
Other director grants: Fred Hassan $36,300 + 8,067 RSUs; Richard Pfenniger $36,300 + 8,067 RSUs; Dr. Japour $54,450 + 14,924 RSUs.
Half of each RSU grant vested immediately; remaining half vests quarterly over two years starting Sep 30, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.